Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Did you take more than 400 MG of Bextra a day?

Have any of the following side effects occurred? (Please check all that apply.)

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Ban on Pfizer's Bextra Extends Beyond U.S.

Apr 8, 2005 | AP Hong Kong suspended the sale of the painkiller Bextra on Friday one day after the drug was pulled off U.S. shelves because it has been linked to increased risk of heart attacks and a rare skin condition.

Patients should "stop taking Bextra and contact their physicians about appropriate treatment options," Hong Kong's Health Department said in a news release.

The drug's importer, Pfizer Corporation Hong Kong Ltd., has agreed to immediately stop selling the prescription medication, the department said.

Pfizer Inc. (PFE) suspended sales of Bextra in the U.S. on Thursday at the request of the U.S. Food and Drug Administration. The company said that the FDA cited a risk of serious skin reactions to Bextra.

Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo